ReviewPharmaceuticals (Basel, Switzerland)2011
Antimicrobial, Antiviral and Immunomodulatory Activity Studies of Pelargonium sidoides (EPs
Review in Pharmaceuticals (Basel, Switzerland), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 74 citations in OpenAlex.
- Chemical Composition and Biological Activities ofMolecules (Basel, Switzerland) · 2025Review
- Immunomodulatory Effects ofExpert reviews in molecular medicine · 2025Review
- Efficacy and Safety of YJP-40 in Patients with Acute Bronchitis: A Randomized, Double-Blind, Parallel Group Study.Tuberculosis and respiratory diseases · 2025Article
- Prescription of EPs 7630 is associated with short- and long-term benefits in acute bronchitis: a real-world data analysis.Frontiers in pharmacology · 2025Article
- Unlocking the therapeutic potential ofHeliyon · 2024Article
- The Effectiveness of a Dietary Supplement with Honey, Propolis,Pharmaceuticals (Basel, Switzerland) · 2024Article
- Multiple mechanisms enable broad-spectrum activity of theFrontiers in pharmacology · 2024Review
- Mechanistic Evidence ofPharmaceuticals (Basel, Switzerland) · 2023Review
- EPsInternational journal of molecular sciences · 2023Article
- Review
- Review
- Impact of government policies on individual choices of food and potential impact on outcomes and nutrition among vulnerable population during COVID-19 pandemic in low- to middle-income country: Literature review.SAGE open medicine · 2022Review
- COVID-19 pandemic crisis and food safety: Implications and inactivation strategies.Trends in food science & technology · 2021Review
- Effects ofLaryngoscope investigative otolaryngology · 2021Article
- Anti-SARS-CoV-2 Natural Products as Potentially Therapeutic Agents.Frontiers in pharmacology · 2021Review
- Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections - A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial.Frontiers in pharmacology · 2021Article
- Effects ofJournal of drug assessment · 2020Article
- A Pragmatic Approach to Immunity & Respiratory Viral Infections.Integrative medicine (Encinitas, Calif.) · 2020Article
- Novel kinase platform for the validation of the anti-tubercular activities of Pelargonium sidoides (Geraniaceae).BMC biotechnology · 2020Article
- The Food Systems in the Era of the Coronavirus (COVID-19) Pandemic Crisis.Foods (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pelargonium species contribute significantly to the health care of a large population in the Southern African region, as part of a long-standing medical system intimately linked to traditional healing practices. Most notably, extracts of the roots of P. sidoides have commonly been applied for the treatment of dysentery and diarrhoea but only occasionally for respiratory complaints. Clinical trials have shown that a modern aqueous-ethanolic formulation of P. sidoides extracts (EPs
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.